Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Traxion Sab De Cv Ord Shs GRPOF

Grupo Traxion SAB de CV is a Mexico-based company engaged in the transportation sector. The Company provides logistics services within eight business areas: Fright, including intermodal and multimodal services, door-to-door, national and cross-border distribution, among others; Integrated logistics, including logistics management, aerial and maritime services and custom transportation support services; Warehousing, including dedicated storage, shared warehouses, packing and value-added services, such as labeling and products assembly; Logistics systems, including software for logistics management; Passenger transportation, including transportation of personnel and students; Special services, including rental of bus and vans; Moving, including national and international moving services, and Advertising, including custom transportation services during marketing campaigns. The Company operates through a number of group companies.


PINL:GRPOF - Post by User

Post by JoeRoganBNNon Feb 14, 2018 8:37am
202 Views
Post# 27556185

10$ Per Share 2020 50$ per share 2025

10$ Per Share 2020 50$ per share 2025To sum it up, 10x multiple for DIN for PP0001 or 12-15x multiple on sales. More importantly, 
DIN for smokeable p0001 will open the door for shorter and I mean shorter trial phases for other ailements (100’s) with the same or similar formulations that will be used for treatment, hence why 50$ a share will be likely by 2025 if things go as planned.  If Pp0001 doesn’t get approved, (unlikely based on preliminary and historic data) then we’ll be stuck at levels and slightly higher than we are now with other ongoing trials. Needless to say, if you bought in at these prices, then the worse case scenario you’ll keep what you’ve invested.  Moreover, I’ll be watching the Jeff Sessions trial as this will undoubtly have an short or long term mpact on SP.

<< Previous
Bullboard Posts
Next >>